Reviewed by Gotrade Internal Analyst
Jakarta, Gotrade News - Palantir Technologies Inc. just secured a massive contract worth $448 million with the United States Navy. This strategic deal is all about using artificial intelligence to manage the supply chain for their nuclear submarine fleet.
Keytakeaways:
- Palantir secures a $448 million contract to modernize the US nuclear submarine supply chain.
- The ShipOS program uses AI to fix critical shipbuilding bottlenecks.
- Analysts predict this project could become Palantir's biggest program, surpassing Project Maven.
This news immediately sent PLTR stock flying, climbing over 2% during the morning trading session. The data analytics company has been on a tear, skyrocketing nearly 142% throughout 2025.
Why Is This a "Game Changer"?
The US Navy is currently struggling to hit their annual submarine production targets. Reports show that production volume is still lagging behind targets for both the Virginia and Columbia classes.
Enter ShipOS, a new initiative designed to speed up shipbuilding through data-driven workflows. According to Palantir, this program will smash through legacy system bottlenecks to identify production risks proactively.
Long-term Potential for Investors
Market analysts see this deal as a major green flag for the company's revenue growth. Louis DiPalma from William Blair noted in his report that this contract has the potential to become Palantir's biggest program, even outperforming Project Maven.
Technical market data also shows strong momentum from both institutional and retail investors. As reported by IBD Stock Checkup, Palantir currently holds a near-perfect Composite Rating of 99 out of 99.
Referensi:
- Investor's Business Daily, Palantir Wins U.S. Navy Contract For Nuclear Submarine Fleet. Potential Bigger Than Maven?. Accessed on December 11, 2025
- Featured Image: Shutterstock
Disclaimer:
Gotrade is the trading name of Gotrade Securities Inc., registered with and supervised by the Labuan Financial Services Authority (LFSA). This content is for educational purposes only and does not constitute financial advice. Always do your own research (DYOR) before investing.
